185 related articles for article (PubMed ID: 12114299)
1. Neurological and neuroendocrine-cytokine inter-relationship in the antiphospholipid syndrome.
Chapman J; Shoenfeld Y
Ann N Y Acad Sci; 2002 Jun; 966():415-24. PubMed ID: 12114299
[TBL] [Abstract][Full Text] [Related]
2. CNS dysfunction in the antiphospholipid syndrome.
Katzav A; Chapman J; Shoenfeld Y
Lupus; 2003; 12(12):903-7. PubMed ID: 14714909
[TBL] [Abstract][Full Text] [Related]
3. Lessons from experimental APS models.
Shoenfeld Y; Ziporen L
Lupus; 1998; 7 Suppl 2():S158-61. PubMed ID: 9814695
[TBL] [Abstract][Full Text] [Related]
4. Genetic and immunological factors interact in a mouse model of CNS antiphospholipid syndrome.
Katzav A; Litvinjuk Y; Pick CG; Blank M; Shoenfeld Y; Sirota P; Chapman J
Behav Brain Res; 2006 May; 169(2):289-93. PubMed ID: 16530276
[TBL] [Abstract][Full Text] [Related]
5. Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies.
Shrot S; Katzav A; Korczyn AD; Litvinju Y; Hershenson R; Pick CG; Blank M; Zaech J; Shoenfeld Y; Sirota P; Chapman J
Lupus; 2002; 11(11):736-43. PubMed ID: 12475004
[TBL] [Abstract][Full Text] [Related]
6. Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome.
Yelnik CM; Kozora E; Appenzeller S
Curr Rheumatol Rep; 2016 Feb; 18(2):11. PubMed ID: 26923254
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid syndrome: state of the art with emphasis on laboratory evaluation.
Greaves M
Haemostasis; 2000; 30 Suppl 2():16-25. PubMed ID: 11251337
[TBL] [Abstract][Full Text] [Related]
8. The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome.
Krause I; Blank M; Fraser A; Lorber M; Stojanovich L; Rovensky J; Shoenfeld Y
Immunobiology; 2005; 210(10):749-54. PubMed ID: 16325493
[TBL] [Abstract][Full Text] [Related]
9. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibody syndrome.
Kutteh WH; Hinote CD
Obstet Gynecol Clin North Am; 2014 Mar; 41(1):113-32. PubMed ID: 24491987
[TBL] [Abstract][Full Text] [Related]
11. Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies.
Chapman J; Rand JH; Brey RL; Levine SR; Blatt I; Khamashta MA; Shoenfeld Y
Lupus; 2003; 12(7):514-7. PubMed ID: 12892390
[TBL] [Abstract][Full Text] [Related]
12. Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurology.
Sanna G; Bertolaccini ML; Hughes GR
Ann N Y Acad Sci; 2005 Jun; 1051():465-86. PubMed ID: 16126988
[TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
14. Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model.
Ziporen L; Shoenfeld Y; Levy Y; Korczyn AD
J Clin Invest; 1997 Aug; 100(3):613-9. PubMed ID: 9239409
[TBL] [Abstract][Full Text] [Related]
15. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
17. Neurological presentations of the antiphospholipid syndrome: three illustrative cases.
De Maeseneire Ch; Duray MC; Rutgers MP; Gille M
Acta Neurol Belg; 2014 Jun; 114(2):117-23. PubMed ID: 24464766
[TBL] [Abstract][Full Text] [Related]
18. The antiphospholipid syndrome.
Wautrecht JC
Acta Neurol Belg; 2002 Dec; 102(4):158-62. PubMed ID: 12534241
[TBL] [Abstract][Full Text] [Related]
19. Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies?
Noureldine MH; Harifi G; Berjawi A; Haydar AA; Nader M; Elnawar R; Sweid A; Al Saleh J; Khamashta MA; Uthman I
Lupus; 2016 Nov; 25(13):1397-1411. PubMed ID: 27225212
[TBL] [Abstract][Full Text] [Related]
20. Obstetric antiphospholipid syndrome: an update on pathophysiology and management.
Ernest JM; Marshburn PB; Kutteh WH
Semin Reprod Med; 2011 Nov; 29(6):522-39. PubMed ID: 22161465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
